APAC’s pharmaceutical packaging industry is evolving as India, China, Singapore and other countries expand their pharmaceutical manufacturing and exports. From smart packaging and serialization to sustainable materials and sterile solutions, companies are adapting to the needs of complex medicines and global supply chains. At the same time, the sector is creating new opportunities across packaging, quality, technology, R&D and regulatory roles.
Pharmaceutical packaging in Asia-Pacific is moving beyond basic protection. Growing pharmaceutical manufacturing, exports, biologics and specialty medicines are increasing demand for safer, smarter and more sustainable packaging.
According to Towards Healthcare Research and Consulting, APAC pharmaceutical market was valued at US$ 464.82 billion in 2025, including US$26.5 billion in exports, while China has become the world’s second-largest pharmaceutical industry.
India: The Pharmacy of the World Needs Smarter Packaging
India remains one of APAC’s biggest pharmaceutical manufacturing and export hubs. Pharmaceutical exports reached around US$31 billion in FY2025–26, while the domestic market was around US$29 billion.
This is creating demand for blister packs, bottles, vials, prefilled syringes, sterile packaging, serialization and tamper-evident solutions.
India’s pharmaceutical manufacturing sector employed 925,811 people in FY2022–23, showing the scale of the ecosystem supporting drug production and packaging.
China: Packaging Is Following the Innovation Boom
China is increasingly focused on innovative medicines and biotechnology. In 2025, China approved 76 innovative drugs, compared with 48 in 2024, while overseas licensing transactions exceeded US$130 billion.
As innovative drugs and biologics expand, demand is rising for high-performance containers, sterile systems and specialized packaging materials.
China also introduced dedicated GMP requirements for pharmaceutical packaging materials and excipients in 2025, strengthening quality and regulatory oversight.
APAC Demand Is Being Driven by More Complex Medicines
Vaccines, biologics, injectables, cell therapies and temperature-sensitive medicines require packaging that provides stronger protection during storage and transportation.
Singapore is a strong example, with more than 60 biopharmaceutical manufacturing plants and biopharmaceutical output exceeding S$18 billion in 2023. Eight of the world’s top 10 biopharmaceutical companies have manufacturing facilities there.
Innovation Is Moving Inside the Package
Smart packaging is becoming more common across pharmaceutical supply chains. Serialization, QR codes, NFC, digital labels and track-and-trace systems are helping companies improve authentication and product visibility.
Sustainability is another priority, with manufacturers exploring lightweight, recyclable and material-efficient packaging without compromising drug safety or sterility.
APAC Is Gaining Global Packaging Exposure
APAC is no longer viewed only as a manufacturing destination. India, China, Singapore, Japan and South Korea are becoming increasingly connected to global pharmaceutical development and supply chains.
Events such as Pharmapack Asia 2026 in Singapore are further increasing international collaboration across pharmaceutical packaging, drug delivery and manufacturing.
The Challenges Behind the Opportunity
APAC offers major opportunities, but its diverse regulatory and manufacturing environment creates challenges.
Key challenges include:
- Different regulatory and labeling requirements
- Pressure to reduce packaging waste
- Counterfeit medicines and supply-chain risks
- Complex requirements for biologics and injectables
- Dependence on specialized packaging materials
- High investment in automation and digital systems
Where the Biggest Opportunities Are Emerging
Opportunities are growing around sterile packaging, biologics, prefilled drug-delivery systems, smart labels, sustainable materials, cold-chain packaging and automated inspection.
India benefits from its large generic and export base, China from its expanding innovative-drug ecosystem, while Singapore and other advanced APAC hubs are creating demand for high-specification packaging.
Jobs: A Wider Career Path Than Packaging Alone
Pharmaceutical packaging is creating opportunities across engineering, production, quality, regulatory affairs, automation, sustainability, R&D and technical sales.
India’s pharma PLI programme had generated around 97,000 jobs by September 2025, while Singapore’s 2025 investments are expected to create 15,700 jobs over five years, including roles in manufacturing, R&D and innovation.
For professionals, pharma packaging is becoming a strong intersection of pharmaceuticals, engineering, materials, technology and sustainability. APAC is increasingly treating packaging as a critical part of how medicines are protected, tracked and delivered, not just packed.
Visit Towards Healthcare for more : https://www.towardshealthcare.com/
Comments (0)